This paper examines ethical tensions surrounding genetic information in healthcare by analyzing a patient case from three stakeholder perspectives: the individual seeking early diagnosis, employers balancing workforce costs, and insurers managing risk. It contrasts genetic testing with genetic manipulation, discusses the ethical implications of predictive genetic knowledge, and analyzes how films like Gattaca and Moon illustrate discrimination risks in a genomically transparent future. The paper highlights the conflict between individual medical benefit and collective social risk assessment, and the challenge of using genetic data responsibly without enabling unjust discrimination.
From Terri's perspective, early genetic detection of her illness is medically necessary—early diagnosis is required for successful treatment. She has a clear personal health interest in pursuing testing. However, without robust legal protections, she faces a cascading financial and employment crisis. Because she is employed at will, she could be fired without cause if her genetic status becomes known. Losing her job would mean losing employer-provided health insurance, a catastrophic combination in the American system.
While the Affordable Care Act now allows her to obtain insurance through the government marketplace regardless of preexisting conditions, marketplace insurance is unlikely to match the coverage or cost of her previous employer plan. She may face higher premiums and reduced benefits. Moreover, finding a new job while undergoing treatment for a genetic illness is extremely difficult in a competitive labor market. Terri thus confronts a tragic bind: the knowledge that would save her life could also destroy her economic stability.
From the employer's viewpoint, the economic calculus is straightforward. If Terri is not classified as disabled under the Americans with Disabilities Act (ADA), she receives no statutory protection against termination. An employer has a financial incentive to remove a potentially costly employee from its workforce. An employee with a genetic predisposition to illness or an actual illness diagnosis may require greater healthcare utilization, raising the collective insurance premiums the employer pays on behalf of its workforce. From a pure cost-containment perspective, avoiding or shedding such employees is rational business behavior.
The insurance company faces a different but related constraint. Federal law now prohibits insurance companies from denying coverage or charging higher premiums based on preexisting conditions for individual policies. However, the law does not prevent insurers from charging employers higher premiums if their workforce profile includes sicker members. Alternatively, insurers can charge sick individuals higher premiums based on the medical care they are predicted to need. In both cases, the cost burden is transferred: either to the employer (and eventually to employees through reduced wages or benefits) or to the sick individual (through higher premiums), or both. The financial incentive to identify and account for genetic risk remains intact even if overt discrimination is forbidden.
A crucial ethical distinction emerges when genetic testing is compared with genetic manipulation. Genetic testing reveals risk—it uncovers information about a predisposition or condition without changing it. Genetic manipulation, by contrast, would eliminate the genetic vulnerability itself, effectively "fixing" the problematic genes.
From an economic standpoint, this distinction is profound. Manipulation would likely reduce long-term healthcare costs compared to a lifetime of treatment and management. A cured employee would impose no ongoing financial burden on an employer or insurer. Consequently, an employer would have less incentive to fire or avoid hiring someone whose genetic illness had been eliminated through manipulation. The ethical problem—using genetic information as a tool for discrimination—would largely disappear if the information were paired with a permanent solution. Testing alone, however, creates an information asymmetry: knowledge without remedy becomes a liability.
The films Gattaca and Moon depict speculative futures in which genetic testing has become so routine, accurate, and inexpensive that the future of every individual can be known with confidence. As scientists continue to map the human genome and develop predictive algorithms, the fear is that anyone carrying genetic markers associated with early death, criminal behavior, or illness will be systematically denied opportunities—employment, insurance, social status, even romantic partnership.
In Gattaca, the protagonist carries a genetic marker for a heart condition. This marker is factually true—he does later suffer a heart attack. However, the film raises a critical ambiguity: many genetic predispositions manifest as statistical tendencies rather than certainties. A genetic marker for higher aggression does not guarantee criminal behavior; a marker for heart disease does not ensure an early death. The film shows a society that treats probabilistic information as deterministic, closing doors based on risk rather than actual outcomes.
The ethical danger is clear: as more genetic information becomes available and the science of prediction improves, the temptation to use that information for discrimination will intensify. Insurance companies and employers will face pressure—and will have financial incentive—to select against anyone carrying unfavorable genetic markers. Individuals will be judged not by their actions or achievements but by the genetic hand they were dealt at conception.
Yet the film also hints at a counterargument. In Moon, the protagonist is sent to the lunar base despite genetic vulnerabilities because his work is deemed essential and the knowledge of his condition allows for appropriate precautions. Complete ignorance of genetic information could also be unethical—people with known medical conditions could be prevented from undertaking risky activities or could receive proactive treatment that might extend their lives. The ethical problem is not genetic knowledge itself but the fairness and transparency of how that knowledge is used.
"Dilemma: genetic knowledge is medically necessary but discriminatorily dangerous"
Always verify citation format against your institution’s current style guide requirements.